Figure 7.
Figure 7. Dendritic cells from A20 lymphoma-bearing mice have impaired antigen-presenting capabilities. BALB/c mice were injected intravenously with 1 × 106 A20 WT lymphoma cells. Three weeks later, animals were killed and CD11c+ splenic DCs were isolated by magnetic sorting. Purified anti-HA T cells (2 × 106) were then plated for 10 hours with 2 × 105 DCs from lymphoma-bearing (right) or control tumor-free (left) mice in the presence or absence of cognate peptide. Each dot plot is gated on the CD4+/6.5+ clonotypic population and shows the percentage of anti-HA T cells positive for IL-2 or IFN-γ, as determined by intracellular cytokine staining. DCs were obtained from 4 mice, and the experiment was repeated twice with similar results.

Dendritic cells from A20 lymphoma-bearing mice have impaired antigen-presenting capabilities. BALB/c mice were injected intravenously with 1 × 106 A20 WT lymphoma cells. Three weeks later, animals were killed and CD11c+ splenic DCs were isolated by magnetic sorting. Purified anti-HA T cells (2 × 106) were then plated for 10 hours with 2 × 105 DCs from lymphoma-bearing (right) or control tumor-free (left) mice in the presence or absence of cognate peptide. Each dot plot is gated on the CD4+/6.5+ clonotypic population and shows the percentage of anti-HA T cells positive for IL-2 or IFN-γ, as determined by intracellular cytokine staining. DCs were obtained from 4 mice, and the experiment was repeated twice with similar results.

Close Modal

or Create an Account

Close Modal
Close Modal